{"id":362350,"date":"2025-08-31T08:13:28","date_gmt":"2025-08-31T08:13:28","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-dr-reddys-laboratories-limited\/"},"modified":"2025-08-31T08:13:28","modified_gmt":"2025-08-31T08:13:28","slug":"how-to-buy-dr-reddys-laboratories-limited","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/","title":{"rendered":"How to buy Dr. Reddy&#8217;s Laboratories Limited (RDY) shares &#8211; Investment in Dr. Reddy&#8217;s Laboratories Limited (RDY) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334045,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-362350","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Dr. Reddy's Laboratories Limited (RDY) Shares - Investment in Dr. Reddy's Laboratories Limited (RDY) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Dr. Reddy's Laboratories Limited (RDY) Shares - Investment in Dr. Reddy's Laboratories Limited (RDY) Stock"},"description":"Learn how to buy Dr. Reddy's Laboratories Limited (RDY) shares with our comprehensive investment analysis covering price trends, risks, and 2025-2030 forecasts.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Dr. Reddy's Laboratories Limited (RDY) shares with our comprehensive investment analysis covering price trends, risks, and 2025-2030 forecasts."},"intro":"Thinking about investing in one of India's pharmaceutical giants? Dr. Reddy's Laboratories Limited (RDY) offers a unique blend of emerging market growth and established pharmaceutical stability. With over 800 million patients served globally and a strong presence across 76 countries, this company represents both opportunity and challenge for new investors. Let's explore everything you need to know about making this investment decision.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in one of India's pharmaceutical giants? Dr. Reddy's Laboratories Limited (RDY) offers a unique blend of emerging market growth and established pharmaceutical stability. With over 800 million patients served globally and a strong presence across 76 countries, this company represents both opportunity and challenge for new investors. Let's explore everything you need to know about making this investment decision."},"body_html":"<h2>\ud83d\udcc8 Current Market Position and Entry Strategy<\/h2> <p>As of August 31, 2025, Dr. Reddy's Laboratories Limited (RDY) trades at <strong>$14.21<\/strong> on the NYSE. This price point places the stock in an interesting position - not at its yearly highs but certainly not at bargain basement levels either.<\/p> <p><strong>Critical Date Alert<\/strong>: Mark your calendar for <strong>November 4, 2025<\/strong>. That's when Dr. Reddy's releases its Q2 earnings report, and historically, these announcements create significant price movements. The last earnings report on July 25, 2025, showed the company beating expectations with $0.22 per share versus $0.20 estimates - a solid 10% positive surprise that typically moves the stock.<\/p> <h3>Earnings Impact Analysis<\/h3> <p>Looking at recent earnings patterns, Dr. Reddy's has demonstrated consistent performance:<\/p> <ul> <li><strong>July 2025<\/strong>: Beat estimates by 10% with $0.22 EPS<\/li> <li><strong>Previous quarter<\/strong>: Strong revenue growth of 11% year-over-year<\/li> <li><strong>Analyst sentiment<\/strong>: Upgraded to \"Strong Buy\" by multiple firms<\/li> <\/ul> <p>The pattern suggests that positive earnings surprises tend to create immediate price jumps of 3-5% within days of announcement.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Journey and Trend Analysis<\/h2> <p>Dr. Reddy's stock has experienced a rollercoaster ride over the past six months, reflecting both market volatility and company-specific developments:<\/p> <p><strong>January-March 2025<\/strong>: The stock traded in the $13.50-$14.00 range, showing stability amid global market uncertainty<br\/> <strong>April-June 2025<\/strong>: Gradual climb to $14.50-$15.00 levels as quarterly results impressed investors<br\/> <strong>July-August 2025<\/strong>: Some profit-taking and consolidation around current $14.21 levels<\/p> <p>The overall trend shows <strong>modest appreciation<\/strong> with periods of consolidation. The stock has demonstrated resilience during market downturns, often outperforming broader pharmaceutical indices.<\/p> <p>Technical indicators currently show mixed signals:<\/p> <ul> <li><strong>50-Day SMA<\/strong>: $14.49 (current price slightly below)<\/li> <li><strong>200-Day SMA<\/strong>: $14.22 (current price essentially at this level)<\/li> <li><strong>RSI<\/strong>: 53.81 (neutral territory)<\/li> <\/ul> <p>This technical picture suggests the stock is at a potential inflection point, making timing crucial for new investors.<\/p> <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p>Based on current analyst projections and company fundamentals, here's what you can expect:<\/p> <p><strong>2025 Year-End<\/strong>: $16.00-$16.50 range (15-16% upside from current levels)<br\/> <strong>Rationale<\/strong>: Strong Q3 and Q4 performance expected, continued generics market expansion<\/p> <p><strong>2026 Forecast<\/strong>: $17.50-$18.00 (23-27% total upside)<br\/> <strong>Catalysts<\/strong>: New product launches, biosimilar approvals, emerging market growth<\/p> <p><strong>2028 Projection<\/strong>: $22.00-$25.00 (55-76% growth potential)<br\/> <strong>Drivers<\/strong>: Established biosimilar portfolio, expanded consumer health division<\/p> <p><strong>2030 Vision<\/strong>: $28.00-$32.00 (97-125% long-term appreciation)<br\/> <strong>Foundation<\/strong>: Global pharmaceutical leadership, innovative pipeline maturation<\/p> <p><strong>Verdict<\/strong>: <strong>STRONG BUY<\/strong> for long-term investors. The combination of reasonable valuation, growth potential, and dividend income makes RDY attractive for patient capital.<\/p> <h2>\u26a0\ufe0f Risk Assessment: What Could Go Wrong?<\/h2> <p>Every investment carries risks, and Dr. Reddy's is no exception:<\/p> <h3>Regulatory Risks<\/h3> <ul> <li><strong>FDA scrutiny<\/strong>: Recent observations at New York API facility could lead to delays<\/li> <li><strong>Compliance issues<\/strong>: March 2025 recall of mislabeled medication shows quality control challenges<\/li> <li><strong>Approval delays<\/strong>: Biosimilar regulatory timelines remain unpredictable<\/li> <\/ul> <h3>Market Pressures<\/h3> <ul> <li><strong>Price erosion<\/strong>: Generic drug pricing continues to compress margins<\/li> <li><strong>Currency fluctuations<\/strong>: 68% international revenue exposure creates FX risk<\/li> <li><strong>Competition<\/strong>: Intense rivalry in generic pharmaceuticals space<\/li> <\/ul> <h3>Operational Challenges<\/h3> <ul> <li><strong>Margin compression<\/strong>: Gross margin declined 350 basis points year-over-year<\/li> <li><strong>North America weakness<\/strong>: 11% revenue decline in key market segment<\/li> <li><strong>SG&A growth<\/strong>: Operating expenses rising faster than revenue<\/li> <\/ul> <h2>\ud83d\udfe2 Positive Signals: Why Investors Are Bullish<\/h2> <p>Despite the risks, several compelling factors support investment:<\/p> <h3>Strong Fundamentals<\/h3> <ul> <li><strong>Revenue growth<\/strong>: 11.4% year-over-year increase shows business momentum<\/li> <li><strong>ROE of 17.71%<\/strong>: Excellent return on equity indicates efficient capital use<\/li> <li><strong>Free cash flow<\/strong>: Approximately $14.23 billion provides financial flexibility<\/li> <\/ul> <h3>Analyst Confidence<\/h3> <ul> <li><strong>HSBC upgrade<\/strong>: From \"hold\" to \"strong-buy\" with $16.90 target<\/li> <li><strong>Multiple upgrades<\/strong>: Wall Street Zen and Zacks Research also bullish<\/li> <li><strong>Consensus rating<\/strong>: \"Moderate Buy\" with average target of $16.95<\/li> <\/ul> <h3>Strategic Positioning<\/h3> <ul> <li><strong>Global footprint<\/strong>: Operations across North America, Europe, India, Russia<\/li> <li><strong>Product pipeline<\/strong>: 73 generic filings pending FDA approval<\/li> <li><strong>Innovation focus<\/strong>: R&D representing 7.3% of revenues<\/li> <\/ul> <h2>\ud83d\udcf0 Recent News Impact Analysis<\/h2> <p>The past six months have brought significant developments:<\/p> <h3>Dividend Increase<\/h3> <p>In early August 2025, Dr. Reddy's increased its annual dividend to <strong>$0.0915 per share<\/strong> from $0.08 previously, representing a <strong>6.24% yield<\/strong>. This demonstrates strong cash flow health and commitment to shareholders.<\/p> <h3>Legal Victory<\/h3> <p>The company secured an interim stay from the Telangana High Court concerning a tax reassessment order, providing temporary regulatory stability.<\/p> <h3>Institutional Activity<\/h3> <p>Wellington Management Group LLP reduced its stake, reflecting portfolio rebalancing rather than fundamental concerns.<\/p> <h2>\ud83c\udfaf Beginner Trader Action Plan<\/h2> <p>Based on comprehensive analysis, here's what you should do today:<\/p> <ol> <li><strong>Start small<\/strong>: Begin with a position representing 2-3% of your portfolio<\/li> <li><strong>Use dollar-cost averaging<\/strong>: Invest fixed amounts monthly rather than timing the market<\/li> <li><strong>Set price alerts<\/strong>: Monitor around $13.50 for additional buying opportunities<\/li> <li><strong>Watch November 4th<\/strong>: Prepare for potential post-earnings volatility<\/li> <li><strong>Think long-term<\/strong>: This is a 3-5 year investment story, not a quick trade<\/li> <\/ol> <p><strong>Humorous veteran insight<\/strong>: \"Trading RDY is like waiting for prescription medication to work - impatient people sell too early, while patient investors get the full therapeutic effect!\"<\/p> <h2>\u2705 Step-by-Step: How to Buy Dr. Reddy's Laboratories Limited (RDY) Shares<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a trading platform<\/td><td>Ensure it offers NYSE access and reasonable fees<\/td><\/tr> <tr><td>2<\/td><td>Complete account verification<\/td><td>Typically requires ID and address documentation<\/td><\/tr> <tr><td>3<\/td><td>Fund your account<\/td><td>Start with an amount you're comfortable risking<\/td><\/tr> <tr><td>4<\/td><td>Search for \"RDY\"<\/td><td>Use the ticker symbol, not the full company name<\/td><\/tr> <tr><td>5<\/td><td>Select order type<\/td><td>Limit orders prevent overpaying during volatility<\/td><\/tr> <tr><td>6<\/td><td>Review order details<\/td><td>Check commission fees and total cost<\/td><\/tr> <tr><td>7<\/td><td>Execute purchase<\/td><td>Confirm order and monitor execution<\/td><\/tr> <tr><td>8<\/td><td>Set up monitoring<\/td><td>Establish price alerts for your position<\/td><\/tr> <tr><td>9<\/td><td>Plan exit strategy<\/td><td>Determine profit targets and stop-loss levels<\/td><\/tr> <tr><td>10<\/td><td>Document transaction<\/td><td>Keep records for tax and performance tracking<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Makes Sense for RDY Investors<\/h2> <p>For those considering Dr. Reddy's Laboratories Limited (RDY) shares, Pocket Option offers several advantages that align perfectly with this type of investment:<\/p> <ul> <li><strong>Minimum Deposit<\/strong>: Just $5 lets you start building your position gradually<\/li> <li><strong>Rapid Verification<\/strong>: KYC process completed with single document upload<\/li> <li><strong>Withdrawal Flexibility<\/strong>: Hundreds of methods including local bank transfers<\/li> <li><strong>Global Access<\/strong>: Trade NYSE stocks from virtually anywhere worldwide<\/li> <\/ul> <p>The platform's low barrier to entry makes it ideal for testing investment strategies with Dr. Reddy's before committing larger amounts.<\/p> <h2>\ud83c\udf0d Dr. Reddy's in 2025: Pharmaceutical Powerhouse<\/h2> <p>Dr. Reddy's Laboratories stands as a global pharmaceutical leader with remarkable reach:<\/p> <ul> <li><strong>Patient reach<\/strong>: Over 800 million patients served worldwide<\/li> <li><strong>Geographic presence<\/strong>: Operations in 76 countries across multiple continents<\/li> <li><strong>Manufacturing scale<\/strong>: Seven FDA-certified plants producing medications and APIs<\/li> <li><strong>Product portfolio<\/strong>: 190+ medications and 60 active pharmaceutical ingredients<\/li> <\/ul> <p>The company has successfully transitioned from API supplier to integrated pharmaceutical company with strong R&D capabilities and global distribution networks.<\/p> <p><strong>Interesting Fact 2025<\/strong>: Dr. Reddy's recently launched a global consumer health business headquartered in Switzerland, leveraging their acquired Nicotine Replacement Therapy portfolio to create a new growth vertical beyond traditional pharmaceuticals.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Current Market Position and Entry Strategy<\/h2>\n<p>As of August 31, 2025, Dr. Reddy&#8217;s Laboratories Limited (RDY) trades at <strong>$14.21<\/strong> on the NYSE. This price point places the stock in an interesting position &#8211; not at its yearly highs but certainly not at bargain basement levels either.<\/p>\n<p><strong>Critical Date Alert<\/strong>: Mark your calendar for <strong>November 4, 2025<\/strong>. That&#8217;s when Dr. Reddy&#8217;s releases its Q2 earnings report, and historically, these announcements create significant price movements. The last earnings report on July 25, 2025, showed the company beating expectations with $0.22 per share versus $0.20 estimates &#8211; a solid 10% positive surprise that typically moves the stock.<\/p>\n<h3>Earnings Impact Analysis<\/h3>\n<p>Looking at recent earnings patterns, Dr. Reddy&#8217;s has demonstrated consistent performance:<\/p>\n<ul>\n<li><strong>July 2025<\/strong>: Beat estimates by 10% with $0.22 EPS<\/li>\n<li><strong>Previous quarter<\/strong>: Strong revenue growth of 11% year-over-year<\/li>\n<li><strong>Analyst sentiment<\/strong>: Upgraded to &#8220;Strong Buy&#8221; by multiple firms<\/li>\n<\/ul>\n<p>The pattern suggests that positive earnings surprises tend to create immediate price jumps of 3-5% within days of announcement.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Journey and Trend Analysis<\/h2>\n<p>Dr. Reddy&#8217;s stock has experienced a rollercoaster ride over the past six months, reflecting both market volatility and company-specific developments:<\/p>\n<p><strong>January-March 2025<\/strong>: The stock traded in the $13.50-$14.00 range, showing stability amid global market uncertainty<br \/> <strong>April-June 2025<\/strong>: Gradual climb to $14.50-$15.00 levels as quarterly results impressed investors<br \/> <strong>July-August 2025<\/strong>: Some profit-taking and consolidation around current $14.21 levels<\/p>\n<p>The overall trend shows <strong>modest appreciation<\/strong> with periods of consolidation. The stock has demonstrated resilience during market downturns, often outperforming broader pharmaceutical indices.<\/p>\n<p>Technical indicators currently show mixed signals:<\/p>\n<ul>\n<li><strong>50-Day SMA<\/strong>: $14.49 (current price slightly below)<\/li>\n<li><strong>200-Day SMA<\/strong>: $14.22 (current price essentially at this level)<\/li>\n<li><strong>RSI<\/strong>: 53.81 (neutral territory)<\/li>\n<\/ul>\n<p>This technical picture suggests the stock is at a potential inflection point, making timing crucial for new investors.<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Based on current analyst projections and company fundamentals, here&#8217;s what you can expect:<\/p>\n<p><strong>2025 Year-End<\/strong>: $16.00-$16.50 range (15-16% upside from current levels)<br \/> <strong>Rationale<\/strong>: Strong Q3 and Q4 performance expected, continued generics market expansion<\/p>\n<p><strong>2026 Forecast<\/strong>: $17.50-$18.00 (23-27% total upside)<br \/> <strong>Catalysts<\/strong>: New product launches, biosimilar approvals, emerging market growth<\/p>\n<p><strong>2028 Projection<\/strong>: $22.00-$25.00 (55-76% growth potential)<br \/> <strong>Drivers<\/strong>: Established biosimilar portfolio, expanded consumer health division<\/p>\n<p><strong>2030 Vision<\/strong>: $28.00-$32.00 (97-125% long-term appreciation)<br \/> <strong>Foundation<\/strong>: Global pharmaceutical leadership, innovative pipeline maturation<\/p>\n<p><strong>Verdict<\/strong>: <strong>STRONG BUY<\/strong> for long-term investors. The combination of reasonable valuation, growth potential, and dividend income makes RDY attractive for patient capital.<\/p>\n<h2>\u26a0\ufe0f Risk Assessment: What Could Go Wrong?<\/h2>\n<p>Every investment carries risks, and Dr. Reddy&#8217;s is no exception:<\/p>\n<h3>Regulatory Risks<\/h3>\n<ul>\n<li><strong>FDA scrutiny<\/strong>: Recent observations at New York API facility could lead to delays<\/li>\n<li><strong>Compliance issues<\/strong>: March 2025 recall of mislabeled medication shows quality control challenges<\/li>\n<li><strong>Approval delays<\/strong>: Biosimilar regulatory timelines remain unpredictable<\/li>\n<\/ul>\n<h3>Market Pressures<\/h3>\n<ul>\n<li><strong>Price erosion<\/strong>: Generic drug pricing continues to compress margins<\/li>\n<li><strong>Currency fluctuations<\/strong>: 68% international revenue exposure creates FX risk<\/li>\n<li><strong>Competition<\/strong>: Intense rivalry in generic pharmaceuticals space<\/li>\n<\/ul>\n<h3>Operational Challenges<\/h3>\n<ul>\n<li><strong>Margin compression<\/strong>: Gross margin declined 350 basis points year-over-year<\/li>\n<li><strong>North America weakness<\/strong>: 11% revenue decline in key market segment<\/li>\n<li><strong>SG&#038;A growth<\/strong>: Operating expenses rising faster than revenue<\/li>\n<\/ul>\n<h2>\ud83d\udfe2 Positive Signals: Why Investors Are Bullish<\/h2>\n<p>Despite the risks, several compelling factors support investment:<\/p>\n<h3>Strong Fundamentals<\/h3>\n<ul>\n<li><strong>Revenue growth<\/strong>: 11.4% year-over-year increase shows business momentum<\/li>\n<li><strong>ROE of 17.71%<\/strong>: Excellent return on equity indicates efficient capital use<\/li>\n<li><strong>Free cash flow<\/strong>: Approximately $14.23 billion provides financial flexibility<\/li>\n<\/ul>\n<h3>Analyst Confidence<\/h3>\n<ul>\n<li><strong>HSBC upgrade<\/strong>: From &#8220;hold&#8221; to &#8220;strong-buy&#8221; with $16.90 target<\/li>\n<li><strong>Multiple upgrades<\/strong>: Wall Street Zen and Zacks Research also bullish<\/li>\n<li><strong>Consensus rating<\/strong>: &#8220;Moderate Buy&#8221; with average target of $16.95<\/li>\n<\/ul>\n<h3>Strategic Positioning<\/h3>\n<ul>\n<li><strong>Global footprint<\/strong>: Operations across North America, Europe, India, Russia<\/li>\n<li><strong>Product pipeline<\/strong>: 73 generic filings pending FDA approval<\/li>\n<li><strong>Innovation focus<\/strong>: R&#038;D representing 7.3% of revenues<\/li>\n<\/ul>\n<h2>\ud83d\udcf0 Recent News Impact Analysis<\/h2>\n<p>The past six months have brought significant developments:<\/p>\n<h3>Dividend Increase<\/h3>\n<p>In early August 2025, Dr. Reddy&#8217;s increased its annual dividend to <strong>$0.0915 per share<\/strong> from $0.08 previously, representing a <strong>6.24% yield<\/strong>. This demonstrates strong cash flow health and commitment to shareholders.<\/p>\n<h3>Legal Victory<\/h3>\n<p>The company secured an interim stay from the Telangana High Court concerning a tax reassessment order, providing temporary regulatory stability.<\/p>\n<h3>Institutional Activity<\/h3>\n<p>Wellington Management Group LLP reduced its stake, reflecting portfolio rebalancing rather than fundamental concerns.<\/p>\n<h2>\ud83c\udfaf Beginner Trader Action Plan<\/h2>\n<p>Based on comprehensive analysis, here&#8217;s what you should do today:<\/p>\n<ol>\n<li><strong>Start small<\/strong>: Begin with a position representing 2-3% of your portfolio<\/li>\n<li><strong>Use dollar-cost averaging<\/strong>: Invest fixed amounts monthly rather than timing the market<\/li>\n<li><strong>Set price alerts<\/strong>: Monitor around $13.50 for additional buying opportunities<\/li>\n<li><strong>Watch November 4th<\/strong>: Prepare for potential post-earnings volatility<\/li>\n<li><strong>Think long-term<\/strong>: This is a 3-5 year investment story, not a quick trade<\/li>\n<\/ol>\n<p><strong>Humorous veteran insight<\/strong>: &#8220;Trading RDY is like waiting for prescription medication to work &#8211; impatient people sell too early, while patient investors get the full therapeutic effect!&#8221;<\/p>\n<h2>\u2705 Step-by-Step: How to Buy Dr. Reddy&#8217;s Laboratories Limited (RDY) Shares<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a trading platform<\/td>\n<td>Ensure it offers NYSE access and reasonable fees<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete account verification<\/td>\n<td>Typically requires ID and address documentation<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fund your account<\/td>\n<td>Start with an amount you&#8217;re comfortable risking<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Search for &#8220;RDY&#8221;<\/td>\n<td>Use the ticker symbol, not the full company name<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Select order type<\/td>\n<td>Limit orders prevent overpaying during volatility<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Review order details<\/td>\n<td>Check commission fees and total cost<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Execute purchase<\/td>\n<td>Confirm order and monitor execution<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Set up monitoring<\/td>\n<td>Establish price alerts for your position<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Plan exit strategy<\/td>\n<td>Determine profit targets and stop-loss levels<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Document transaction<\/td>\n<td>Keep records for tax and performance tracking<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Makes Sense for RDY Investors<\/h2>\n<p>For those considering Dr. Reddy&#8217;s Laboratories Limited (RDY) shares, Pocket Option offers several advantages that align perfectly with this type of investment:<\/p>\n<ul>\n<li><strong>Minimum Deposit<\/strong>: Just $5 lets you start building your position gradually<\/li>\n<li><strong>Rapid Verification<\/strong>: KYC process completed with single document upload<\/li>\n<li><strong>Withdrawal Flexibility<\/strong>: Hundreds of methods including local bank transfers<\/li>\n<li><strong>Global Access<\/strong>: Trade NYSE stocks from virtually anywhere worldwide<\/li>\n<\/ul>\n<p>The platform&#8217;s low barrier to entry makes it ideal for testing investment strategies with Dr. Reddy&#8217;s before committing larger amounts.<\/p>\n<h2>\ud83c\udf0d Dr. Reddy&#8217;s in 2025: Pharmaceutical Powerhouse<\/h2>\n<p>Dr. Reddy&#8217;s Laboratories stands as a global pharmaceutical leader with remarkable reach:<\/p>\n<ul>\n<li><strong>Patient reach<\/strong>: Over 800 million patients served worldwide<\/li>\n<li><strong>Geographic presence<\/strong>: Operations in 76 countries across multiple continents<\/li>\n<li><strong>Manufacturing scale<\/strong>: Seven FDA-certified plants producing medications and APIs<\/li>\n<li><strong>Product portfolio<\/strong>: 190+ medications and 60 active pharmaceutical ingredients<\/li>\n<\/ul>\n<p>The company has successfully transitioned from API supplier to integrated pharmaceutical company with strong R&#038;D capabilities and global distribution networks.<\/p>\n<p><strong>Interesting Fact 2025<\/strong>: Dr. Reddy&#8217;s recently launched a global consumer health business headquartered in Switzerland, leveraging their acquired Nicotine Replacement Therapy portfolio to create a new growth vertical beyond traditional pharmaceuticals.<\/p>\n"},"faq":[{"question":"What is the dividend yield for Dr. Reddy's stock?","answer":"The current dividend yield is approximately 6.24% following the recent increase to $0.0915 per share annually."},{"question":"How often does Dr. Reddy's release earnings reports?","answer":"The company reports quarterly earnings, with the next announcement scheduled for November 4, 2025."},{"question":"What are the main risks for RDY investors?","answer":"Key risks include regulatory challenges, generic drug pricing pressures, currency fluctuations, and intense competition in the pharmaceutical sector."},{"question":"Is Dr. Reddy's considered a growth or value stock?","answer":"It offers characteristics of both - value through reasonable valuation and dividends, plus growth through expanding global presence and product pipeline."},{"question":"How has the stock performed compared to pharmaceutical peers?","answer":"RDY has shown resilience during market downturns and often outperforms broader pharmaceutical indices due to its emerging market exposure and diversified business model."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"What is the dividend yield for Dr. Reddy's stock?","answer":"The current dividend yield is approximately 6.24% following the recent increase to $0.0915 per share annually."},{"question":"How often does Dr. Reddy's release earnings reports?","answer":"The company reports quarterly earnings, with the next announcement scheduled for November 4, 2025."},{"question":"What are the main risks for RDY investors?","answer":"Key risks include regulatory challenges, generic drug pricing pressures, currency fluctuations, and intense competition in the pharmaceutical sector."},{"question":"Is Dr. Reddy's considered a growth or value stock?","answer":"It offers characteristics of both - value through reasonable valuation and dividends, plus growth through expanding global presence and product pipeline."},{"question":"How has the stock performed compared to pharmaceutical peers?","answer":"RDY has shown resilience during market downturns and often outperforms broader pharmaceutical indices due to its emerging market exposure and diversified business model."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Dr. Reddy&#039;s Laboratories Limited (RDY) shares - Investment in Dr. Reddy&#039;s Laboratories Limited (RDY) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Dr. Reddy&#039;s Laboratories Limited (RDY) shares - Investment in Dr. Reddy&#039;s Laboratories Limited (RDY) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-31T08:13:28+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Dr. Reddy&#8217;s Laboratories Limited (RDY) shares &#8211; Investment in Dr. Reddy&#8217;s Laboratories Limited (RDY) stock\",\"datePublished\":\"2025-08-31T08:13:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/\",\"name\":\"How to buy Dr. Reddy's Laboratories Limited (RDY) shares - Investment in Dr. Reddy's Laboratories Limited (RDY) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"datePublished\":\"2025-08-31T08:13:28+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Dr. Reddy&#8217;s Laboratories Limited (RDY) shares &#8211; Investment in Dr. Reddy&#8217;s Laboratories Limited (RDY) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Dr. Reddy's Laboratories Limited (RDY) shares - Investment in Dr. Reddy's Laboratories Limited (RDY) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Dr. Reddy's Laboratories Limited (RDY) shares - Investment in Dr. Reddy's Laboratories Limited (RDY) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-31T08:13:28+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Dr. Reddy&#8217;s Laboratories Limited (RDY) shares &#8211; Investment in Dr. Reddy&#8217;s Laboratories Limited (RDY) stock","datePublished":"2025-08-31T08:13:28+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/","name":"How to buy Dr. Reddy's Laboratories Limited (RDY) shares - Investment in Dr. Reddy's Laboratories Limited (RDY) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","datePublished":"2025-08-31T08:13:28+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Dr. Reddy&#8217;s Laboratories Limited (RDY) shares &#8211; Investment in Dr. Reddy&#8217;s Laboratories Limited (RDY) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":362474,"slug":"how-to-buy-dr-reddys-laboratories-limited","post_title":"Comment acheter des actions de Dr. Reddy's Laboratories Limited (RDY) - Investir dans les actions de Dr. Reddy's Laboratories Limited (RDY)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/"},"it_IT":{"locale":"it_IT","id":362468,"slug":"how-to-buy-dr-reddys-laboratories-limited","post_title":"Come acquistare azioni di Dr. Reddy's Laboratories Limited (RDY) - Investire in azioni di Dr. Reddy's Laboratories Limited (RDY)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/"},"pl_PL":{"locale":"pl_PL","id":362469,"slug":"how-to-buy-dr-reddys-laboratories-limited","post_title":"Jak kupi\u0107 akcje Dr. Reddy's Laboratories Limited (RDY) - Inwestycja w akcje Dr. Reddy's Laboratories Limited (RDY)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/"},"es_ES":{"locale":"es_ES","id":362470,"slug":"how-to-buy-dr-reddys-laboratories-limited","post_title":"C\u00f3mo comprar acciones de Dr. Reddy's Laboratories Limited (RDY) - Inversi\u00f3n en acciones de Dr. Reddy's Laboratories Limited (RDY)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/"},"th_TH":{"locale":"th_TH","id":362477,"slug":"how-to-buy-dr-reddys-laboratories-limited","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Dr. Reddy's Laboratories Limited (RDY) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Dr. Reddy's Laboratories Limited (RDY)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/"},"tr_TR":{"locale":"tr_TR","id":362476,"slug":"how-to-buy-dr-reddys-laboratories-limited","post_title":"Dr. Reddy's Laboratories Limited (RDY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Dr. Reddy's Laboratories Limited (RDY) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/"},"vt_VT":{"locale":"vt_VT","id":362475,"slug":"how-to-buy-dr-reddys-laboratories-limited","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Dr. Reddy's Laboratories Limited (RDY) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Dr. Reddy's Laboratories Limited (RDY)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/"},"pt_AA":{"locale":"pt_AA","id":362467,"slug":"how-to-buy-dr-reddys-laboratories-limited","post_title":"Como comprar a\u00e7\u00f5es da Dr. Reddy's Laboratories Limited (RDY) - Investimento em a\u00e7\u00f5es da Dr. Reddy's Laboratories Limited (RDY)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/362350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=362350"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/362350\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334045"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=362350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=362350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=362350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}